Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

2010 Company Financials: Orthopaedic and Spine



  • Worldwide hip/knee sales +2% (U.S. +2%)
  • Continued deceleration in procedure volume growth, increased price mix pressure
  • Average selling prices (ASP) for U.S. hips/knees declined slightly in low single digits; ASP decline worse than previous quarter
  • Performance improving in U.K., especially Germany
  • International performance very solid, with strong double-digit growth in Australia
  • Growth in Japan decelerated into single digits (partially due to price decreases from 4/10)


  • Continued mix shift from metal-on-metal (MoM) acetabular systems to RingLoc cups with E1 bearings in U.S. and to Exceed ABT in Europe
  • Noticing some impact of MoM shift on company‚Äôs overall market share, some price impact, especially in Europe, where metal-on-poly alternatives offer lower price point
  • Will complete initial U.S. launch of Arcos Modular Revision Hip in 3Q
  • Launching additional sets for Arcos throughout end of FY11, into FY12
  • Rollout of new Taperloc Complete Hip in 4Q


  • Vanguard, E1 Tibial Bearings and Regenerex Porous Titanium key supporters of knee growth
  • Received FDA clearance for Vanguard SSK 360 Revision for stabilized knee; will commence limited launch during 3Q
  • Trained ~250 U.S. surgeons on Oxford knee
  • Will commence limited launch of Oxford Partial Knee extensions and instrument upgrades during fiscal year


  • Double-digit growth for 12th consecutive quarter worldwide and 10th consecutive for U.S.
  • ExploR Modular Radial Head, primary reverse and fracture shoulder systems strong contributors to growth
  • Trained ~250 U.S. surgeons (strong focus on comprehensive shoulder), will train 150 more during 3Q

Trauma and Spine

  • Trauma hardware operations business now fully transferred into U.S. orthopaedic division
  • Strong craniomaxillofacial fixation sales offset by decreased sales in internal/external fixation, electrical stimulation
  • Planning 3Q release of IQ intelligent delivery system for increased speed of titanium screw insertion with cordless drilling
  • Significant price pressure in spine hardware continues
  • Spinal stimulation supported by strong sales of SpinalPak
  • Expects increased market demand in 2HFY11 for Polaris Deformity System with Trivium derotation instruments for scoliosis, and for MaxAn Anterior Cervical Plate


  • Soft goods/bracing sales decreased, but sports med supported by increased demand for JuggerKnot Soft Anchor, MaxFire MarXmen meniscal repair device, etc.
  • Completed patient enrollment in U.S. clinical trial for Recover Kit to treat chronic tennis elbow: 230 patients, will conclude mid-calendar 2011